skip to primary navigationskip to content

Over the winter break you have more time to reflect on the next steps - we thought you might be interested in the following opportunity with EF.

last modified Dec 22, 2015 12:23 PM

Entrepreneur First is the best place for Europe’s top technical individuals to meet, and build world-changing startups in London. We’re Europe’s leading pre-seed investor in deep technology companies. We help the 100 smartest technical individuals, like you, build their companies from scratch, often before they have a team or an idea. We’ve created 40 companies so far, now worth hundreds of millions of dollars. EF was created because we genuinely believe that if you’re technical and ambitious, starting a company is the most exciting career option open to you right now. We select purely on the basis of technical talent, so you can apply before you have a team or a fully formed idea.

If you’re interested, put in an application on our site to make sure you don’t miss our deadline, 31st Dec, for the March & September 2016 programmes

You might have some questions- I’d love to chat in January - you can reach me via email  

OPdA Tweets

Upcoming events

Postdoc lunchtime talks series: Understand research grants and contracts

Mar 30, 2017

Rayleigh Seminar Room, Maxwell Centre, University of Cambridge, JJ Thomson Avenue, CB3 0HE

Getting a Fellowship - for science/engineering postdocs

Mar 31, 2017

LG19, Law Faculty, Cambridge

Upcoming events

RSS Feed Latest news

Job Opportunity - Postdoc Research Staff Co-ordinator (Part Time)

Mar 27, 2017

The OPdA is looking to appoint an experienced co-coordinator to provide a core service supporting the Postdocs of Cambridge (PdOC) Society and the wider postdoc community of 4,000.

Industry exchange funding for biomedical science and technology - apply by 5 April

Mar 21, 2017

Academics and industrial collaborators may apply for funding to carry out collaborative research in any area of biomedical science and technology through the Cambridge Academy of Therapeutic Sciences.

View all news